Valeo Pharma (TSE:VPH) Stock Price Down 20%

Valeo Pharma Inc. (TSE:VPH)’s share price dropped 20% during trading on Monday . The stock traded as low as C$0.04 and last traded at C$0.04. Approximately 406,125 shares were traded during mid-day trading, an increase of 587% from the average daily volume of 59,115 shares. The stock had previously closed at C$0.05.

Valeo Pharma Stock Down 20.0 %

The stock has a market capitalization of C$3.95 million, a price-to-earnings ratio of -0.15 and a beta of 2.38. The stock has a 50 day moving average price of C$0.08 and a 200 day moving average price of C$0.11.

Valeo Pharma (TSE:VPH) last posted its quarterly earnings data on Thursday, September 12th. The company reported C($0.08) earnings per share for the quarter. The firm had revenue of C$12.60 million during the quarter.

About Valeo Pharma

Valeo Pharma Inc, a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada. Its product portfolio includes Enerzair Breezhaler, a LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, a LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, for the treatment of Idiopathic Parkinson's disease; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma.